arrow_back Back to App

Funding Cap for Medical Research in 2024

This bill proposes to limit spending for the National Center for Advancing Translational Sciences, part of the National Institutes of Health. This means less money will be available for medical research and the development of new therapies in fiscal year 2024. This could impact the pace of progress in treating diseases and the availability of new medicines for citizens.
Key points
The bill sets a maximum of $806,373,000 for the National Center for Advancing Translational Sciences in 2024.
Reduced funding may slow down research into new treatments and disease diagnostics.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 118_HR_1998
Sponsor: Rep. Biggs, Andy [R-AZ-5]
Process start date: 2023-03-29
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To provide for a limitation on availability of funds for Department of Health and Human Services, National Institutes of Health National Center for Advancing Translational Sciences for fiscal year 2024.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 118_HR_1998.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2023-03-29.

What are the main provisions?

Key points include:

  • The bill sets a maximum of $806,373,000 for the National Center for Advancing Translational Sciences in 2024.
  • Reduced funding may slow down research into new treatments and disease diagnostics.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Biggs, Andy [R-AZ-5].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Health.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-24.

CATEGORIES

Health Public Investments